Quest Diagnostics Incorporated (NYSE:DGX) saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. The recent jump in the share price has meant that the company is trading around its 52-week high. As a large-cap stock with high coverage by analysts, you could assume any recent changes in the company’s outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let’s take a look at Quest Diagnostics’s outlook and value based on the most recent financial data to see if the opportunity still exists.
View our latest analysis for Quest Diagnostics
What Is Quest Diagnostics Worth?
Great news for investors – Quest Diagnostics is still trading at a fairly cheap price according to our price multiple model, where we compare the company’s price-to-earnings ratio to the industry average. In this instance, we’ve used the…
